120 related articles for article (PubMed ID: 849604)
1. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. II. Sensitization against melanoma-associated antigens.
Golub SH
Cell Immunol; 1977 Feb; 28(2):379-89. PubMed ID: 849604
[No Abstract] [Full Text] [Related]
2. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. I. Culture conditions resulting in augmented cell-mediated cytotoxicity.
Golub SH
Cell Immunol; 1977 Feb; 28(2):371-8. PubMed ID: 557373
[No Abstract] [Full Text] [Related]
3. Cytotoxic lymphocytes in melanoma patients.
Faucault JP; Bernard JP; Potier JC; Lecacheux C
Int J Cancer; 1972 May; 9(3):567-76. PubMed ID: 4676747
[No Abstract] [Full Text] [Related]
4. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
[TBL] [Abstract][Full Text] [Related]
5. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
[TBL] [Abstract][Full Text] [Related]
6. Sensitisation of lymphocytes in vitro against human melanoma-associated antigens.
Golub SH; Morton DL
Nature; 1974 Sep; 251(5471):161-3. PubMed ID: 4421563
[No Abstract] [Full Text] [Related]
7. Cellular and humoral immunity against human malignant melanoma.
Fossati G; Colnaghi MI; Porta GD; Cascinelli N; Veronesi U
Int J Cancer; 1971 Sep; 8(2):344-50. PubMed ID: 4943925
[No Abstract] [Full Text] [Related]
8. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
Pavie-Fischer J; Kourilsky FM; Picard F; Banzet P; Puissant A
Clin Exp Immunol; 1975 Sep; 21(3):430-41. PubMed ID: 1204255
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.
Wybran J; Hellström I; Hellström KE; Fudenberg HH
Int J Cancer; 1974 Apr; 13(4):515-21. PubMed ID: 4546321
[No Abstract] [Full Text] [Related]
11. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
Cohen AM; Ketcham AS; Morton DL
J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
[No Abstract] [Full Text] [Related]
13. [The lymphocyte cytotoxicity test in tumor immunology (author's transl)].
Pees HW
Klin Wochenschr; 1975 Jan; 53(1):1-6. PubMed ID: 47411
[TBL] [Abstract][Full Text] [Related]
14. [Blocking of cellular cytotoxicity by serum factors in progressive malignant melanoma].
Saal JG; Rieber EP; Hadam M; Riethmüller G; Ehinger H; Wilms K; Wilmanns W
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1217-9. PubMed ID: 611821
[No Abstract] [Full Text] [Related]
15. Destruction of cultivated melanoma cells by lymphocytes from healthy Black (North American Negro) donors.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1973 Jan; 11(1):116-22. PubMed ID: 4790830
[No Abstract] [Full Text] [Related]
16. IgA as a blocking factor in human malignant melanoma.
O'Neill PA; Romsdahl MM
Immunol Commun; 1974; 3(5):427-38. PubMed ID: 4214759
[No Abstract] [Full Text] [Related]
17. Characterization of a chimpanzee anti-human melanoma antiserum.
Stuhlmiller GM; Seigler HF
Cancer Res; 1975 Aug; 35(8):2132-7. PubMed ID: 1149027
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated cytotoxicity for cultured autologous melanoma cells.
Livingston PO; Shiku H; Bean MA; Pinsky CM; Oettgen HF; Old LJ
Int J Cancer; 1979 Jul; 24(1):34-44. PubMed ID: 478690
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
[No Abstract] [Full Text] [Related]
20. Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma.
Pellegrino MA; Ferrone S; Reisfeld RA; Irie RF; Golub SH
Cancer; 1977 Jul; 40(1):36-41. PubMed ID: 69483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
